Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
eClinicalMedicine, 2026
Amgens investigational maridebart caftaglutide (Maritide) targets the GLP-1 receptor and glucose-dependent insulinotropic polypeptide receptor (GIPR)
Insurance coverage for GLP-1 medications varies significantly depending on the indication, specific medication, and insurance plan type
It acts as a signaling molecule, telling your cells to perform certain actions
The right choice depends on your specific goals, and a qualified physician can help you determine the optimal approach
US$ 26.76
US$ 29.48
US$ 23.24
US$ 24.35
US$ 23.03
US$ 20.07
US$ 26.81
US$ 20.34
US$ 23.57
US$ 27.95
US$ 23.77
